论文部分内容阅读
血清抗体IgG的存在乃是慢性布病患者感染过程的重要指征,特异性抗体IgG的测定具有临床诊断重要意义,也是区别免疫接种与自然感染的重要指标。经利凡诺尔(Rivanol)处理后,r-球蛋白IgG不发生沉淀仍保留在血清中,其它蛋白均发生沉淀。FAC/WHO布病专家委员会指出:Rivanolum试验可以取代较烦琐的CFT。该试验应用于人布病抗体的测定在我国尚未见报道,现将用该技术对慢性布病患者血清抗体的观察(同时作SAT,CFT比较)结果报告如下。
The presence of serum antibody IgG is an important indicator of the infection process in patients with chronic brucellosis. The determination of specific antibody IgG has important clinical significance and is also an important indicator of the difference between immunization and natural infection. After treatment with Rivanol, r-globin IgG did not precipitate and remained in serum, and other proteins were precipitated. The FAC / WHO Expert Committee on Brucellosis states that the Rivanolum trial can replace the cumbersome CFT. The test used in the determination of human brucellosis antibody has not been reported in our country, now using this technology in patients with chronic brucellosis serum antibody (also for SAT, CFT comparison) results are reported as follows.